hs-CRP Testing: Inflammation Signal, Not Diagnosis
hs-CRP can add useful context to cardiovascular risk discussions, but it is an inflammation signal, not a diagnosis or a reason to self-medicate.
hs-CRP can add useful context to cardiovascular risk discussions, but it is an inflammation signal, not a diagnosis or a reason to self-medicate.
Magnesium may help some poor sleepers, but trials are small and product-specific. Safety, kidney function, and medicine interactions still matter.
Grip strength can flag muscle and function risk in later life, but it is a marker, not a verdict. Training should build the whole body safely.
A post-meal walk can blunt glucose rises for some adults, but timing, meal size, medicines, and diabetes risk all change what the evidence means.
Fermented foods may support gut-health markers, but the evidence is food-specific, cautious, and weaker than most wellness claims suggest for longevity.
Weekend catch-up sleep may ease short-term tiredness, but it is not a full repair strategy for chronic sleep debt. Here is where the evidence lands.
Menopause brain fog is common and usually subtle, but hormone therapy is not a simple cognitive fix. Here is what the evidence says and when to seek review.
HRV biofeedback may help some adults practise stress regulation, but the evidence is mixed and it should not replace anxiety or cardiac care.
Lp(a) is mostly inherited and usually silent. A one-time blood test can clarify heart risk, but results need clinical context rather than panic.
Berberine may modestly lower glucose in type 2 diabetes, but supplement quality, medicine interactions, and pregnancy risks keep the case cautious.